Neuroprotective compounds and uses thereof
The present invention relates to a neuroprotective compound consisting of the amino acid sequence DLHW.
1. A neuroprotective compound consisting of the amino acid sequence DLHW (SEQ ID NO: 2).
2. The composition of claim 1 , wherein the composition is adapted for intravenous, intramuscular, spinal, epidural, transdermal, parenteral, oral, enteral, intranasal or rectal administration.
3. A pharmaceutical composition comprising a neuroprotective compound consisting of the amino acid sequence DLHW (SEQ ID NO: 2).
4. The composition of claim 3 , further comprising a pharmaceutically acceptable excipient and/or carrier.
5. The composition of claim 3 , further comprising at least one additional pharmaceutically active component.
6. The composition of claim 5 , wherein the at least one pharmaceutically active component is tetrapeptide L-alanyl-L-glutamyl-L-asparagyl-L-proline or cerebrolysin.
7. The composition of claim 3 , wherein the compound is comprised in the composition in an amount of 0.1 μg/g to 100 mg/g.
8. The composition of claim 7 , wherein the compound is comprised in the composition in an amount of 1 μg to 80 mg/g.